Clare Bryant

Clare Bryant is Professor of Innate Immunity in the Departments of Medicine and Veterinary Medicine at the University of Cambridge, UK. She is a key figure in innate immunity, particularly with respect to inflammasome biology, whose multi-disciplinary research has answered fundamental mechanistic questions investigating how macrophages respond to infection. She is listed by Thompson Reuters/ Clarivates in the top 1% of pharmacologists in the world, based on citations per paper. Professor Bryant is a founder of an antimicrobial company (Polypharmakos), has a drug discovery project with Apollo Therapeutics, and is a SAB member of a number of pharma companies in the UK and the USA.